Our present results show that the dyskinesia and histopathological deterioration after SCI/R are apparently alleviated by the natural flavonoid astragalin, and we have also verified amelioration of astragalin administration to oxidative stress and inflammation, which are similar to the effects of RIP1 inhibitor necrostatin-1. Here, RIPK1 is linked to drug-induced dyskinesia.